5 rezultatima
FIELD OF THE INVENTION
The present invention relates to the field of therapeutic treatments of eye disorders. More specifically, the invention relates to the administration of VEGF antagonists to treat eye disorders caused by or associated with angiogenesis.
BACKGROUND
Several eye disorders are
BACKGROUND
The Vascular Endothelial Growth Factor (VEGF) family of growth factors and their receptors are essential regulators of angiogenesis and vascular permeability. The VEGF family comprises VEGF-A, PIGF (placenta growth factor), VEGF-B, VEGF-C, VEGF-E and snake venom VEGF and each is thought
FIELD OF THE INVENTION
The present invention relates to the field of therapeutic treatments of eye disorders. More specifically, the invention relates to the administration of VEGF antagonists to treat eye disorders caused by or associated with angiogenesis.
BACKGROUND
Several eye disorders are
FIELD OF THE INVENTION
The present invention relates to the field of therapeutic treatments of eye disorders. More specifically, the invention relates to the administration of VEGF antagonists to treat eye disorders caused by or associated with angiogenesis.
BACKGROUND
Several eye disorders are
FIELD OF THE INVENTION
The present invention relates to pharmaceutical formulations comprising an ophthalmic medication typically applied by intravitreal injection to the eye and a liposomal deliver agent that permits topical application to the eye of said intravitreal medication. The present